Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiac Screening of Middle Aged and Older Women and Men (Master Athletes) (MASTERSCREEN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02923518
Recruitment Status : Completed
First Posted : October 4, 2016
Last Update Posted : August 31, 2018
Sponsor:
Information provided by (Responsible Party):
LHL Helse

Brief Summary:
In 2010 there was published new European recommendations for assessment of adult and elderly men and women, who want to start with physical activity and/or participate in endurance contests. In this study we want to test if a group of people with positive score on a self-reported questionnaire and/or high-risk score in a risk scoring system (NORRISK) have more undetected heart diseases than a control group with no reported or detected risk factors.

Condition or disease Intervention/treatment
Heart Disease Other: Questionnaire

Detailed Description:

Forty senior athletes between 35 to approximately 80 yrs old with a positive score will be included in one group, and another forty seniors without positive score in a control group. Each of them will be tested with an cardiorespiratory exercise test (CPET) with ECG and examined with echocardiography together with an usual medical examination and blood tests (cholesterol and HbA1c-glucose). Some with symptoms of arrhythmias will be examined by 24-hours Holter-monitoring.

The main purpose of the study is to assess if men and women with a positive score on the questionnaire og NORRISK-screening (risk calculator for coronary heart disease) have more detectable heart diseases than the control group.

Layout table for study information
Study Type : Observational
Actual Enrollment : 86 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Cardiac Screening of Middle Aged and Older Women and Men (Master Athletes) Who Participate in Long Distance Endurance Training and Competitions.
Study Start Date : October 2016
Actual Primary Completion Date : November 2017
Actual Study Completion Date : November 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Diseases

Group/Cohort Intervention/treatment
Inclusion group
Inclusion group: Those with a positive score in a questionnaire including symptoms and family history and/or high risk-score in the NORRISK-score system.
Other: Questionnaire
Observational study without any intervention described under intervention type

Control group
Those without a positive score on the two scores listed above.
Other: Questionnaire
Observational study without any intervention described under intervention type




Primary Outcome Measures :
  1. Differences among two groups of senior athletes in detecting heart diseases by a screening program [ Time Frame: One year ]
    Examine if a simple screening program is efficient in detecting heart diseases



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   35 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Senior men and women < 35 yrs participating in long-enurance competitions. 40 persons in a group with positive score and one group without.
Criteria

Inclusion Criteria:

> 35 yrs old Master athletes Positive score on symptom based questionnaire or high risk score No known heart disease Participated in long-term endurance competitions

Exclusion Criteria:

< 35 yrs old Known heart disease


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02923518


Locations
Layout table for location information
Norway
LHL-clinics Feiring
Feiring, Norway, 2093
Sponsors and Collaborators
LHL Helse
Investigators
Layout table for investigator information
Study Director: Hege Lundring, M.D. General manager the LHL-clinics

Layout table for additonal information
Responsible Party: LHL Helse
ClinicalTrials.gov Identifier: NCT02923518    
Other Study ID Numbers: 2016/21007
First Posted: October 4, 2016    Key Record Dates
Last Update Posted: August 31, 2018
Last Verified: August 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by LHL Helse:
Heart Screening
Master Athletes
Cardiovascular Disease
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Diseases
Cardiovascular Diseases